An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Ma, Lina ^a   Huang, Yanyan ^a   Zhu, Wangyu ^a   Zhou, Shiquan ^a   Zhou, Jihang ^a   Zeng, Fang ^a   Liu, Xiaoguang ^a   Zhang, Yongkui ^a   Yu, Jun ^a,b  

^a Zhoushan Hospital BIG/CAS   (China)

^b Chinese Academy of Sciences and China National Center for Bioinformation   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; MICRORNA; MICRORNA 96; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CANCER TISSUE; CELL DIFFERENTIATION; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MOLECULAR INTERACTION; NUCLEOTIDE SEQUENCE; UPREGULATION; VALIDATION PROCESS; GENETICS; TUMOR CELL LINE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CPG ISLANDS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER;

EID: 80055026432     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026502     Document Type: Article

References (67)

1. Cancer., (2009) Cancer Geneva, Switzerland World Health Organization.
2. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, et al. (1995) Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109: 120-129.
3. Hoffman PC, Mauer AM, Vokes EE, (2000) Lung cancer. Lancet 355: 479-485.
4. Flehinger BJ, Kimmel M, Melamed MR, (1992) The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest 101: 1013-1018.
5. Mountain CF, (1997) Revisions in the International System for Staging Lung Cancer. Chest 111: 1710-1717.
6. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, et al. (2010) Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466: 869-873.
7. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T, (2001) Identification of novel genes coding for small expressed RNAs. Science 294: 853-858.
8. Hutvagner G, Zamore PD, (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science 297: 2056-2060.
9. Ruvkun G, (2006) Clarifications on miRNA and cancer. Science 311: 36-37.
10. Nunez-Iglesias J, Liu CC, Morgan TE, Finch CE, Zhou XJ, (2010) Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS One 5: e8898.
11. Clop A, (2009) Insights into the importance of miRNA-related polymorphisms to heart disease. Hum Mutat 30: v.
12. Haramati S, Chapnik E, Sztainberg Y, Eilam R, Zwang R, et al. (2010) miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A 107: 13111-13116.
13. Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, et al. (2010) MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 120: 1298-1309.
14. Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, et al. (2009) Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 27: 2030-2037.
15. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
16. Wang XC, Du LQ, Tian LL, Wu HL, Jiang XY, et al. (2010) Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer 72: 92-99.
17. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
18. Saviozzi S, Ceppi P, Novello S, Ghio P, Lo Iacono M, et al. (2009) Non-small cell lung cancer exhibits transcript overexpression of genes associated with homologous recombination and DNA replication pathways. Cancer Res 69: 3390-3396.
19. Chang JW, Yi CA, Son DS, Choi N, Lee J, et al. (2008) Prediction of lymph node metastasis using the combined criteria of helical CT and mRNA expression profiling for non-small cell lung cancer. Lung Cancer 60: 264-270.
20. Jeong HC, Kim EK, Lee JH, Yoo HN, Kim JK, (2011) Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. Mol Med Report 4: 383-387.
21. Duncan D, Prodduturi N, Zhang B, (2010) WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. BMC Bioinformatics 11: 1-1.
22. Yi R, Qin Y, Macara IG, Cullen BR, (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17: 3011-3016.
23. Gregory RI, Shiekhattar R, (2005) MicroRNA biogenesis and cancer. Cancer Res 65: 3509-3512.
24. Lee Y, Jeon K, Lee JT, Kim S, Kim VN, (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21: 4663-4670.
25. Lee Y, Ahn C, Han J, Choi H, Kim J, et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
26. Zhang B, Wang Q, Pan X, (2007) MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 210: 279-289.
27. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230.
28. Doench JG, Sharp PA, (2004) Specificity of microRNA target selection in translational repression. Genes Dev 18: 504-511.
29. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB, (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798.
30. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
31. Brennecke J, Stark A, Russell RB, Cohen SM, (2005) Principles of microRNA-target recognition. PLoS Biol 3: e85.
32. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
33. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
34. Enright AJ, John B, Gaul U, Tuschl T, Sander C, et al. (2003) MicroRNA targets in Drosophila. Genome Biol 5: R1.
35. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, et al. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39: 457-466.
36. Saxonov S, Berg P, Brutlag DL, (2006) A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci U S A 103: 1412-1417.
37. Zheng YL, Kosti O, Loffredo CA, Bowman E, Mechanic L, et al. (2009) Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case-control study. Int J Cancer 126: 2199-2210.
38. Wang W, Spitz MR, Yang H, Lu C, Stewart DJ, et al. (2007) Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. Clin Cancer Res 13: 5974-5981.
39. Nambu Y, Beer DG, (2003) Altered surface markers in lung cancer. Lack of cell-surface Fas/APO-1 expression in pulmonary adenocarcinoma may allow escape from immune surveillance. Methods Mol Med 74: 259-266.
40. Shimada K, Yasuda S, (1984) Studies on immune response of human lung cancer by cell surface antigen. Rinsho Kyobu Geka 4: 53-60.
41. Huang B, Sikorski R, Sampath P, Thorne SH, (2011) Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer. J Immunother 34: 289-296.
42. Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, et al. (2002) miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev 16: 720-728.
43. Kuhn S, Johnson SL, Furness DN, Chen J, Ingham N, et al. (2011) miR-96 regulates the progression of differentiation in mammalian cochlear inner and outer hair cells. Proc Natl Acad Sci U S A 108: 2355-2360.
44. Jensen KP, Covault J, Conner TS, Tennen H, Kranzler HR, et al. (2009) A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors. Mol Psychiatry 14: 381-389.
45. Han Y, Chen J, Zhao X, Liang C, Wang Y, et al. (2011) MicroRNA Expression Signatures of Bladder Cancer Revealed by Deep Sequencing. PLoS One 6: e18286.
46. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, et al. (2010) Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 126: 1166-1176.
47. Agirre X, Jimenez-Velasco A, San Jose-Eneriz E, Garate L, Bandres E, et al. (2008) Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res 6: 1830-1840.
48. Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, et al. (2010) MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci 102: 522-529.
49. Lin H, Dai T, Xiong H, Zhao X, Chen X, et al. (2011) Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS One 5: e15797.
50. Guttilla IK, White BA, (2009) Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 284: 23204-23216.
51. Guo H, Ingolia NT, Weissman JS, Bartel DP, (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
52. Wang L, Oberg AL, Asmann YW, Sicotte H, McDonnell SK, et al. (2009) Genome-wide transcriptional profiling reveals microRNA-correlated genes and biological processes in human lymphoblastoid cell lines. PLoS One 4: e5878.
53. Jin M, Kawakami K, Fukui Y, Tsukioka S, Oda M, et al. (2009) Different histological types of non-small cell lung cancer have distinct folate and DNA methylation levels. Cancer Sci 100: 2325-2330.
54. Vaissiere T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, et al. (2009) Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 69: 243-252.
55. Choi KC, Lee YH, Jung MG, Kwon SH, Kim MJ, et al. (2009) Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells. Mol Cancer Res 7: 2011-2021.
56. Tani M, Ito J, Nishioka M, Kohno T, Tachibana K, et al. (2004) Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells. Genes Chromosomes Cancer 40: 146-151.
57. Dickstein J, Senyuk V, Premanand K, Laricchia-Robbio L, Xu P, et al. (2010) Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome. Proc Natl Acad Sci U S A 107: 9783-9788.
58. Roccaro AM, Sacco A, Jia X, Azab AK, Maiso P, et al. (2010) microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia. Blood 116: 1506-1514.
59. Sharif J, Endo TA, Toyoda T, Koseki H, (2010) Divergence of CpG island promoters: a consequence or cause of evolution? Dev Growth Differ 52: 545-554.
60. Bird A, (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21.
61. Roh TY, Cuddapah S, Zhao K, (2005) Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev 19: 542-552.
62. Edwards JR, O'Donnell AH, Rollins RA, Peckham HE, Lee C, et al. (2011) Chromatin and sequence features that define the fine and gross structure of genomic methylation patterns. Genome Res 20: 972-980.
63. Okitsu CY, Hsieh CL, (2007) DNA methylation dictates histone H3K4 methylation. Mol Cell Biol 27: 2746-2757.
64. Van Den Broeck A, Ozenne P, Eymin B, Gazzeri S, (2010) Lung cancer: a modified epigenome. Cell Adh Migr 4: 107-113.
65. Kondo Y, (2009) Epigenetic cross-talk between DNA methylation and histone modifications in human cancers. Yonsei Med J 50: 455-463.
66. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
67. Ye J, Fang L, Zheng H, Zhang Y, Chen J, et al. (2006) WEGO: a web tool for plotting GO annotations. Nucleic Acids Res 34: W293-297.